- Home
- KRMD vs EQH Comparison
KRMD vs EQH Comparison
Compare KRMD & EQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- EQH
- Stock Information
- Founded
- KRMD 1980
- EQH 1859
- Country
- KRMD United States
- EQH United States
- Employees
- KRMD N/A
- EQH N/A
- Industry
- KRMD Medical/Dental Instruments
- EQH Specialty Insurers
- Sector
- KRMD Health Care
- EQH Finance
- Exchange
- KRMD Nasdaq
- EQH Nasdaq
- Market Cap
- KRMD 126.9M
- EQH N/A
- IPO Year
- KRMD N/A
- EQH N/A
- Fundamental
- Price
- KRMD $3.15
- EQH $51.34
- Analyst Decision
- KRMD Strong Buy
- EQH Buy
- Analyst Count
- KRMD 4
- EQH 12
- Target Price
- KRMD $4.63
- EQH $60.25
- AVG Volume (30 Days)
- KRMD 113.3K
- EQH 2.5M
- Earning Date
- KRMD 05-07-2025
- EQH 04-29-2025
- Dividend Yield
- KRMD N/A
- EQH 1.87%
- EPS Growth
- KRMD N/A
- EQH 13.70
- EPS
- KRMD N/A
- EQH 3.76
- Revenue
- KRMD $35,083,740.00
- EQH $15,105,000,000.00
- Revenue This Year
- KRMD $16.50
- EQH $25.93
- Revenue Next Year
- KRMD $15.47
- EQH $1.90
- P/E Ratio
- KRMD N/A
- EQH $13.68
- Revenue Growth
- KRMD 19.65
- EQH 45.39
- 52 Week Low
- KRMD $1.86
- EQH $36.46
- 52 Week High
- KRMD $5.05
- EQH $56.00
- Technical
- Relative Strength Index (RSI)
- KRMD 64.92
- EQH 56.21
- Support Level
- KRMD $2.51
- EQH $49.63
- Resistance Level
- KRMD $3.35
- EQH $52.14
- Average True Range (ATR)
- KRMD 0.19
- EQH 1.29
- MACD
- KRMD 0.09
- EQH 0.39
- Stochastic Oscillator
- KRMD 81.31
- EQH 85.78
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).